The COVID-19 public health emergency expires this spring, bringing an end to pandemic-related funding, infrastructure, and flexibilities. Meanwhile, millions of people continue struggling to find and pay for effective treatment for post-acute, COVID-related conditions. Karen Davenport provides an update on the progress—or lack thereof—towards covering the ongoing and unique care needs of these COVID “long haulers.”
New health policy research topped CHIR’s list of beach reads this July. For the latest monthly research roundup, we reviewed studies on marketplace enrollees’ denied claims, how marketplace coverage has benefitted small business and self-employed workers, and out-of-pocket spending on insulin.
COVID-19 survivors may experience new symptoms well after their initial infection. Health systems offer these patients help with managing their conditions, but COVID-19 is a novel disease, and research demonstrating effectiveness of treatments for many post-COVID conditions is sparse. Karen Davenport takes a look at some of insurance implications of the dearth of information on “long COVID.”
The ACA established new appeal rights for consumers facing a denial of a benefit or service from their health plan. As consumers start to use their new Marketplace coverage, JoAnn Volk takes a look at the health plan appeals process required of all new plans, and what these new rights mean for patients.
The opinions expressed here are solely those of the individual blog post authors and do not represent the views of Georgetown University, the Center on Health Insurance Reforms, any organization that the author is affiliated with, or the opinions of any other author who publishes on this blog.
